From professional translators, enterprises, web pages and freely available translation repositories.
dyslipidemia
dislipidemija
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
chmp/1268/04 treatment of dyslipidemia
chmp/1268/04 4. 1 terapins indikacijos
Last Update: 2008-03-04
Usage Frequency: 1
Quality:
Warning: This alignment may be wrong.
Please delete it you feel so.
consultation with standard guidelines for management of dyslipidemia is recommended.
rekomenduojama laikytis standartini dislipidemijos gydymo rekomendacij.
Last Update: 2008-03-04
Usage Frequency: 5
Quality:
Warning: This alignment may be wrong.
Please delete it you feel so.
helsinki heart study: primary prevention with gemfibrozil in middle aged men with dyslipidemia.
happa ir kiti pavadinimu „ helsinkio Širdies studijos: pirminė prevencija vartojant gemfibrozilį vidutinio amžiaus vyrams, sergantiems dislipidemija “ (helsinki heart study: primary prevention with gemfibrozil in middle aged men with dyslipidemia) žurnale the new england journal of medicine 1987 metais (317: 1237- 1245).
Last Update: 2011-10-23
Usage Frequency: 1
Quality:
Warning: This alignment may be wrong.
Please delete it you feel so.
treatment of dyslipidemia mixed dyslipidaemia characterised by hypertriglyceridaemia and/or low hdl-cholesterol.
dislipidemijos gydymas misrioji dislipidemija, pasireiskianti hipertrigliceridemija ir (arba) mazu hdl cholesterolio kiekiu.
Last Update: 2008-03-04
Usage Frequency: 1
Quality:
Warning: This alignment may be wrong.
Please delete it you feel so.
overall, 7,583 subjects with mixed dyslipidemia entered a 6 week statin run-in period.
viso 7 583 asmenims, sergantiems mišriąja dislipidemija, buvo paskirtas 6 savaičių įvadinis statino kursas.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
dyslipidemia is common with elevated ldl and triglycerides and low hdl, associated with increase liver fat content and transaminase elevations.
dažnai išsivysto dislipidemija, lydima mtl ir trigliceridų kiekio padidėjimo bei dtl kiekio sumažėjimo, susijusi su riebalų kiekio kepenyse ir transaminazių aktyvumo padidėjimu.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
dyslipidemia, an increase in hdl-c and decrease in triglycerides (at one year) was observed.
dtl- c koncentracija 20 mg rimonabanto vartojusiems pacientams padidėjo vidutiniškai 16, 4% (dtl- c koncentracija iki tyrimo buvo 1, 24 mmol/ l), o placebą – 8, 9% (dtl- c koncentracija iki tyrimo buvo 1, 21 mmol/ l).
Last Update: 2011-10-23
Usage Frequency: 1
Quality:
Warning: This alignment may be wrong.
Please delete it you feel so.
patients had a bmi 30 kg/m² or bmi 27 kg/m² with hypertension and/or dyslipidemia at inclusion.
tyrimo pradzioje pacient kmi buvo 30 kg/m² arba kmi 27 kg/m², jie sirgo hipertenzija ir (arba) hiperlipidemija.
Last Update: 2008-03-04
Usage Frequency: 2
Quality:
Warning: This alignment may be wrong.
Please delete it you feel so.
patients had a bmi 30 kg/m² or bmi>27 kg/m² with hypertension and/or dyslipidemia at inclusion.
tyrimo pradžioje pacientų kmi buvo 30 kg/m² arba kmi > 27 kg/m², jie sirgo hipertenzija ir (arba) hiperlipidemija.
Last Update: 2017-04-26
Usage Frequency: 1
Quality:
Warning: Contains invisible HTML formatting
patients had a bmi ≥ 30 kg/ m² or bmi > 27 kg/ m² with hypertension and/ or dyslipidemia at inclusion.
tyrimo pradžioje pacientų kmi buvo ≥ 30 kg/ m² arba kmi > 27 kg/ m², jie sirgo hipertenzija ir (arba) hiperlipidemija.
Last Update: 2012-04-11
Usage Frequency: 2
Quality:
Warning: Contains invisible HTML formatting
in clinical studies, reyataz (with or without ritonavir) has been shown to induce dyslipidemia to a lesser extent than comparators (see section 5.1) .
klinikiniai tyrimai parod, kad reyataz (su ritonaviru ar be jo) sukelia mazesn dislipidemij, negu palyginamieji vaistai (zr.5. 1 skyri) .
Last Update: 2008-03-04
Usage Frequency: 5
Quality:
Warning: This alignment may be wrong.
Please delete it you feel so.